Monashee Investment Management LLC purchased a new stake in Korro Bio, Inc. (NASDAQ:KRRO – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 90,805 shares of the company’s stock, valued at approximately $4,352,000. Korro Bio makes up about 0.8% of […]
Korro to Participate in Upcoming June Investor and Scientific Conferences tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Korro Bio (NASDAQ:KRRO – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $100.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. BMO Capital Markets reaffirmed an outperform rating […]
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week.